ivarmacitinib
reistone
['ivarmacitinib', 'derm']
oral #ivarmacitinib demonstrated statistically significant improvement in patients with moderate-to-severe #atopicdermatitis, according to new research presented in a late-breaking research session at #aad2023. 
Dermatology Times: The latest news and trends in dermatologic procedures, therapy, technology, products and drugs.